Total Payments
$4,014
2022 Payments
$303.94
Companies
15
Transactions
38
Medicare Patients
703
Medicare Billing
$103,617
Payment Breakdown by Category
Food & Beverage$2,439 (60.8%)
Research$1,575 (39.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,439 | 37 | 60.8% |
| Unspecified | $1,575 | 1 | 39.2% |
Payments by Type
General
$2,439
37 transactions
Research
$1,575
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $1,672 | 3 | $0 (2019) |
| Medtronic USA, Inc. | $466.23 | 6 | $0 (2018) |
| Genentech USA, Inc. | $397.48 | 4 | $0 (2018) |
| Boston Scientific Corporation | $364.78 | 3 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $259.98 | 2 | $0 (2021) |
| Medtronic Vascular, Inc. | $211.55 | 2 | $0 (2019) |
| Amarin Pharma Inc. | $129.56 | 8 | $0 (2021) |
| Alexion Pharmaceuticals, Inc. | $127.66 | 1 | $0 (2022) |
| Stryker Corporation | $125.35 | 1 | $0 (2017) |
| CSL Behring | $102.34 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $303.94 | 4 | Alexion Pharmaceuticals, Inc. ($127.66) |
| 2021 | $302.97 | 5 | AstraZeneca Pharmaceuticals LP ($259.98) |
| 2020 | $86.57 | 5 | Amarin Pharma Inc. ($86.57) |
| 2019 | $1,998 | 6 | Biogen, Inc. ($1,672) |
| 2018 | $635.38 | 8 | Genentech USA, Inc. ($277.93) |
| 2017 | $687.71 | 10 | Medtronic USA, Inc. ($248.18) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2022 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $59.96 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 10/21/2022 | Alexion Pharmaceuticals, Inc. | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $127.66 | General |
| Category: Rare Disease | ||||||
| 09/22/2022 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $102.34 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 05/18/2022 | Becton, Dickinson and Company | — | Food and Beverage | In-kind items and services | $13.98 | General |
| 11/16/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/30/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $134.99 | General |
| 07/02/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Cardiovascular | ||||||
| 03/09/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: Cardiovascular | ||||||
| 01/26/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Cardiovascular | ||||||
| 12/23/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Cardiovascular | ||||||
| 11/17/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Cardiovascular | ||||||
| 09/03/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Cardiovascular | ||||||
| 05/29/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Cardiovascular | ||||||
| 04/09/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Cardiovascular | ||||||
| 10/17/2019 | Medtronic Vascular, Inc. | Reveal LINQ (Device) | Food and Beverage | In-kind items and services | $65.68 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 09/11/2019 | Medtronic Vascular, Inc. | Reveal LINQ (Device) | Food and Beverage | In-kind items and services | $145.87 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 08/20/2019 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $13.97 | General |
| 06/25/2019 | Biogen, Inc. | — | — | Cash or cash equivalent | $1,575.01 | Research |
| Study: Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction | ||||||
| 02/07/2019 | Biogen, Inc. | — | Food and Beverage | Cash or cash equivalent | $83.04 | General |
| 02/06/2019 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $113.96 | General |
| Category: STRUCTURAL HEART | ||||||
| 11/08/2018 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $119.34 | General |
| Category: Metabolism & Primary Care | ||||||
| 11/02/2018 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $125.90 | General |
| Category: STRUCTURAL HEART | ||||||
| 08/16/2018 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $92.12 | General |
| Category: Metabolism & Primary Care | ||||||
| 05/24/2018 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $66.47 | General |
| Category: Metabolism & Primary Care | ||||||
| 05/03/2018 | Medtronic USA, Inc. | Solitaire (Device) | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: Stents | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction | Biogen, Inc. | $1,575 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 124 | 172 | $76,906 | $19,898 |
| 2022 | 7 | 210 | 287 | $109,744 | $28,788 |
| 2021 | 7 | 243 | 316 | $122,458 | $33,715 |
| 2020 | 4 | 126 | 186 | $76,949 | $21,216 |
Total Patients
703
Total Services
961
Medicare Billing
$103,617
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 34 | 50 | $30,750 | $8,426 | 27.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 37 | $10,656 | $3,480 | 32.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 25 | 25 | $7,400 | $2,261 | 30.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 32 | $6,400 | $2,001 | 31.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $7,840 | $1,919 | 24.5% |
| 93893 | Ultrasound of within the brain blood flow for blood clots with microbubble injection | Office | 2023 | 14 | 14 | $13,860 | $1,812 | 13.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 57 | 78 | $47,970 | $13,239 | 27.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 35 | 60 | $17,280 | $4,825 | 27.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 39 | 39 | $11,544 | $3,214 | 27.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 16 | $8,960 | $2,477 | 27.6% |
| 93886 | Complete ultrasound of within the brain blood flow | Facility | 2022 | 25 | 51 | $6,732 | $1,801 | 26.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 31 | $6,200 | $1,734 | 28.0% |
| 93893 | Ultrasound of within the brain blood flow for blood clots with microbubble injection | Office | 2022 | 12 | 12 | $11,058 | $1,497 | 13.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 61 | 91 | $56,925 | $15,671 | 27.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 42 | 66 | $19,216 | $5,369 | 27.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 47 | 47 | $14,048 | $3,875 | 27.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 22 | 22 | $12,488 | $3,470 | 27.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 39 | 52 | $10,596 | $2,944 | 27.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 16 | 16 | $6,201 | $1,606 | 25.9% |
| 93886 | Ultrasound scanning of head and neck vessel blood flow (inside the brain) | Facility | 2021 | 16 | 22 | $2,984 | $779.94 | 26.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 44 | 72 | $46,008 | $12,492 | 27.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 22 | 40 | $11,840 | $3,359 | 28.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 38 | 39 | $11,856 | $3,334 | 28.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 22 | 35 | $7,245 | $2,031 | 28.0% |
About Dr. Michael Waters, MD
Dr. Michael Waters, MD is a Vascular Neurology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629140561.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Waters, MD has received a total of $4,014 in payments from pharmaceutical and medical device companies, with $303.94 received in 2022. These payments were reported across 38 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($2,439).
As a Medicare-enrolled provider, Waters has provided services to 703 Medicare beneficiaries, totaling 961 services with total Medicare billing of $103,617. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Vascular Neurology
- Other Specialties Vascular Neurology, Neurology
- Location New York, NY
- Active Since 11/15/2006
- Last Updated 01/29/2024
- Taxonomy Code 2084V0102X
- Entity Type Individual
- NPI Number 1629140561
Products in Payments
- Solitaire (Device) $466.23
- Activase (Biological) $397.48
- WATCHMAN (Device) $364.78
- Reveal LINQ (Device) $211.55
- Vascepa (Drug) $129.56
- ANDEXXA (Biological) $127.66
- Trevo (Device) $125.35
- BRILINTA (Drug) $124.99
- Kcentra (Biological) $102.34
- LINQ II (Device) $59.96
- ENSTILAR (Drug) $43.24
- TRULICITY (Drug) $27.00
- Adzenys XR-ODT (Drug) $12.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Vascular Neurology Doctors in New York
Dr. Johanna Fifi, M.d, M.D
Vascular Neurology — Payments: $320,700
Vascular Neurology $320,700
Dr. Shahram Majidi, M.d, M.D
Vascular Neurology — Payments: $108,180
Vascular Neurology $108,180
Koto Ishida, M.d, M.D
Vascular Neurology — Payments: $69,338
Vascular Neurology $69,338
Dr. Steven Levine, M.d, M.D
Vascular Neurology — Payments: $59,975
Vascular Neurology $59,975
Dr. Aaron Tansy, Md, MD
Vascular Neurology — Payments: $2,636
Vascular Neurology $2,636
Clara Boyd, Md, MD
Vascular Neurology — Payments: $677.83
Vascular Neurology $677.83